Anthropic Launches Internal Drug Discovery Program Targeting Neglected Diseases

According to CNBC, Anthropic launched an internal drug discovery program on Tuesday at a San Francisco event, focusing on treatments for neglected diseases that traditional biopharmaceutical companies typically overlook. Life sciences head Eric Kauderer-Abrams said the initiative aims to build better AI tools and products for drugmakers through direct experience and feedback loops. The program complements Anthropic's Claude Science product, designed for life sciences companies.
Disclaimer: The information on this page may come from third-party sources and is for reference only. It does not represent the views or opinions of Gate and does not constitute any financial, investment, or legal advice. Virtual asset trading involves high risk. Please do not rely solely on the information on this page when making decisions. For details, see the Disclaimer.
Comment
0/400
No comments